I am committed to a career in patient-oriented research related to pulmonary vascular disease. Exploring the clinical impact and the mechanisms of pulmonary hypertension (PH) in patients with underlying lung disease is my primary research interest. This interest stems from my clinical experience over the last several years developing and building the Northwestern Pulmonary Hypertension Program. Pulmonary hypertension is a common complication seen in patients with lung disease, specifically chronic obstructive pulmonary disease (COPD). Although the association between the presence of PH in COPD and increased mortality has been well described, we have recently explored the impact of PH on patient-centered outcomes. I am interested in exploring the mechanisms of PH and identifying the disease as it presents early in the course of lung disease when interventions could potentially alter disease progression.